Your browser doesn't support javascript.
loading
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Mina, Roberto; Musto, Pellegrino; Rota-Scalabrini, Delia; Paris, Laura; Gamberi, Barbara; Palmas, Angelo; Aquino, Sara; de Fabritiis, Paolo; Giuliani, Nicola; De Rosa, Luca; Gozzetti, Alessandro; Cellini, Claudia; Bertamini, Luca; Capra, Andrea; Oddolo, Daniela; Vincelli, Iolanda Donatella; Ronconi, Sonia; Pavone, Vincenzo; Pescosta, Norbert; Cea, Michele; Fioritoni, Francesca; Ballanti, Stelvio; Grasso, Mariella; Zamagni, Elena; Belotti, Angelo; Boccadoro, Mario; Gay, Francesca.
Afiliación
  • Mina R; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Musto P; Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy; Hematology and Stem Cell Transplantation Unit, AOU Consorziale Policlinico, Bari, Italy.
  • Rota-Scalabrini D; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO - IRCCS, Turin, Italy.
  • Paris L; Division of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Gamberi B; Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Palmas A; SC Ematologia, Ospedale San Francesco, Nuoro, Italy.
  • Aquino S; Ematologia, Ospedale Policlinico San Martino, Genova, Italy.
  • de Fabritiis P; Haematology, St Eugenio Hospital, Tor Vergata University, Rome, Italy.
  • Giuliani N; University of Parma and University Hospital of Parma, Parma, Italy.
  • De Rosa L; Hematology and SCT Unit, St Camillo Hospital, Rome, Italy.
  • Gozzetti A; Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico S Maria alle Scotte, Siena, Italy.
  • Cellini C; AUSL Romagna, UOC Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy.
  • Bertamini L; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Capra A; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Oddolo D; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Vincelli ID; Hematology Unit, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Ronconi S; IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"-IRST, Meldola, Italy.
  • Pavone V; Department of Hematology and Bone Marrow Transplant, Hospital Cardinale G Panico, Tricase, Italy.
  • Pescosta N; Reparto Ematologia, Ospedale Provinciale Bolzano, Bolzano, Italy.
  • Cea M; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Fioritoni F; Ospedale Santo Spirito, Pescara, Italy.
  • Ballanti S; Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, località Sant'Andrea delle Fratte, Perugia, Italy.
  • Grasso M; Azienda Ospedaliera S Croce-Carle, Cuneo, Italy.
  • Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy; Italy Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
  • Belotti A; UO Ematologia, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Boccadoro M; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Gay F; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. Electronic address: francesca.gay@unito.it.
Lancet Oncol ; 24(1): 64-76, 2023 01.
Article en En | MEDLINE | ID: mdl-36528035
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Italia